Insider Transactions in Q2 2024 at Baxter International Inc (BAX)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 03
2024
|
David S. Rosenbloom EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
784
-0.72%
|
$26,656
$34.08 P/Share
|
Jun 03
2024
|
Christopher A. Toth EVP,Group Pres, Kidney Care |
SELL
Payment of exercise price or tax liability
|
Direct |
15,202
-6.65%
|
$516,868
$34.08 P/Share
|
May 07
2024
|
David Brent Shafer Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,952
+30.99%
|
-
|
May 07
2024
|
Cathy R Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,952
+20.89%
|
-
|
May 07
2024
|
Amy Mc Bride Wendell Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,952
+19.95%
|
-
|
May 07
2024
|
David S. Wilkes Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,952
+26.78%
|
-
|
May 07
2024
|
Peter M Wilver Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,952
+30.97%
|
-
|
May 07
2024
|
William A. Ampofo Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,952
+37.67%
|
-
|
May 07
2024
|
Patricia Morrison Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,952
+21.79%
|
-
|
May 07
2024
|
Stephen N. Oesterle Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,952
+17.58%
|
-
|
May 07
2024
|
Stephen H Rusckowski Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,952
+39.63%
|
-
|
May 07
2024
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,952
+29.42%
|
-
|